Skip to main content
. 2023 Mar 20;15(6):1848. doi: 10.3390/cancers15061848

Table 1.

Criteria of included patients.

Level Overall
n 144
Antiphospholipid antibodies (%) No 141 (97.9)
Yes 3 (2.1)
Primary cancer organ (%) Gynecological 23 (16.0)
Lung 41 (28.5)
Other GIT cancers 19 (13.2)
Others 33 (22.9)
Pancreas 28 (19.4)
Lung vs. other cancers (%) Others 103 (71.5)
Lung cancer 41 (28.5)
Pathology (%) Adenocarcinoma 93 (64.6)
Hematopoietic 6 (4.2)
Others 38 (26.4)
Sarcoma 1 (0.7)
SCC 6 (4.2)
Adenocarcinoma vs. other pathologies (%) Other pathologies 51 (35.4)
Adenocarcinoma 93 (64.6)
Organ of metastasis (n = 97) (%) Bone 5 (5.2)
Brain 3 (3.1)
Liver 23 (23.7)
Lung 7 (7.2)
Lymph nodes 22 (22.7)
Multiple 25 (25.8)
Others 12 (12.4)
Metastasis (n = 141) (%) Non-metastatic 43 (30.7)
Metastatic 97 (69.3)
Marantic presentation before diagnosis of cancer (n = 125) (%) Known cancer case 42 (33.6)
Marantic as first presentation 83 (66.4)
Interval diagnosis (months) (mean (SD) 6.24 (25.51)
Age (median (IQR)) 60.00 (49.75, 66.00)
Sex (%) Females 81 (56.25)
Males 63 (43.75)
COPD (n = 52) (%) No 49 (94.2)
Yes 3 (5.8)
Smoking (n = 56) (%) No 43 (76.8)
Yes 13 (23.2)
Diabetes (n = 52) (%) No 43 (82.7)
Yes 9 (17.3)
Obesity (n = 53) (%) No 52 (98.1)
Yes 1 (1.9)
Dyslipidemia (n = 54) (%) No 46 (85.2)
Yes 8 (14.8)
Hypertension (n = 56) (%) No 36 (64.3)
Yes 20 (35.7)
Embolization event at presentation (n = 132) (%) No 15 (11.4)
Yes 117 (88.6)
Embolic event after diagnosis (n = 125) (%) No 76 (60.8)
Yes 49 (39.2)
Incidental finding of NBTE (%) No 132 (91.7)
Yes 12 (8.3)
Postmortem diagnosis of NBTE (%) No 95 (66.0)
Yes 49 (34.0)
Position of vegetation (n = 132) (%) Aortic 48 (36.4)
Left atrium 1 (0.8)
Mitral 62 (47.0)
Multiple 21 (15.9)
Valve insufficiency (n = 89) (%) No 28 (31.5)
Yes 61 (68.5)
Valve stenosis (n = 90) (%) No 81 (90.0)
Yes 9 (10.0)
Underwent intervention (%) No 123 (85.4)
Yes 21 (14.6)
Type of surgery (%) Excision of vegetation 5 (3.5)
None 123 (85.4)
Replacement 16 (11.1)
Presenting symptoms (n = 139) (%) Cardiological 6 (4.5)
Neurological 96 (72.7)
Others 7 (5.3)
Respiratory 13 (9.8)
Vascular 10 (7.6)
Death (%) No 47 (32.6)
Yes 97 (67.4)
Time to death (days) (median (IQR)) 15.40 (2.73, 56.00)